George Dorfman

George Dorfman currently serves as the Director of Global Strategy & Business Development at Parse Biosciences, a position held since September 2024. Prior experience includes serving as the Associate Director of Cell and Gene Therapy Business and Market Development at Mission Bio from August 2021 to September 2024. Earlier roles encompass Strategic Account Manager at Metabolon, Inc. from June 2019 to August 2021, Business Development Manager at Mitra Biotech, and Director of Business Development at CDI Laboratories, Inc. Additionally, roles include Business Development Manager at Gateway Analytical, Marketing Strategy Consultant at VascuLogic, and Senior Research Technologist at Cleveland Clinic. Academic qualifications include a degree from Rutgers University, where George Dorfman also served as Senior Laboratory Manager and Business Development Manager. Recognized as a nominated researcher by the International Scholar Laureate Program in June 2007.